Dicerna board of directors
WebDICERNA PHARMACEUTICALS, INC. (a Delaware corporation) (Pursuant to Sections 228, 242 and 245 of the ... The Board of Directors shall also have the power to adopt, … WebFeb 10, 2024 · February 10, 2024 by Talent4Boards Team. – USA, MA – Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference therapeutics, today announced the appointment of Stephen Doberstein, Ph.D., Chief Scientific Fellow at Nektar Therapeutics, Inc., to its board of directors as …
Dicerna board of directors
Did you know?
WebGeneral meetings shall be called with 3-5 weeks’ notice. Among others, the Annual General Meeting approves the Annual Report, any amendments to the Articles of Association, elects the chair, the vice chair and 2-8 other members of the Board of Directors as well as the independent auditor. WebFounded: 2007. Type: Company - Public (DRNA) Industry: Biotech & Pharmaceuticals. Revenue: Unknown / Non-Applicable. Competitors: Unknown. Dicerna is working to …
WebSep 19, 2024 · Company Announces Retirement of Board of Director Veteran Dennis Langer ... June 22, 2024 Web`unanimously approved by the Dicerna Board of Directors and the Board of `Directors of Novo Nordisk. . . . ` `Under the terms of the agreement, Novo Nordisk, through a subsidiary, will initiate `a tender offer to acquire all outstanding shares of Dicerna common stock at a price `of $38.25 per share in cash.
WebNov 22, 2024 · The transaction was unanimously approved by the Dicerna Board of Directors and the Board of Directors of Novo Nordisk. Novo Nordisk and Dicerna have been parties to a research collaboration since 2024 to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology. The collaboration … WebSep 19, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 19, 2024-- Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic …
WebEX-10.11 16 d622509dex1011.htm EX-10.11 EX-10.11 . Exhibit 10.11 . EMPLOYMENT AGREEMENT . EMPLOYMENT AGREEMENT (“Agreement”) made this May 6, 2010 between Dicerna Pharmaceuticals, Inc. (“Company’) on the one hand and Douglas M. Fambrough, III (the “Executive”) on the other hand.. WHEREAS the Company desires to …
WebNov 22, 2024 · The investigation focuses on whether Dicerna Pharmaceuticals, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to ... hillsboro fourth of july paradeWebNov 18, 2024 · Novo Nordisk and Dicerna have been parties to a research collaboration since 2024 to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology. smart grid: technology and applicationsWebDicerna is headquartered in Lexington, Massachusetts, the US. Headquarters United States of America. Address 75 Hayden Avenue, Lexington, Massachusetts, 02421. Website … hillsboro g2 flatbedWeb1994 - 200410 years. Senior Vice President, Project, Portfolio and Alliance Management and Member, R&D Executive Committee, … smart grip boschWebDICERNA PHARMACEUTICALS, INC. Dicerna Pharmaceuticals, Inc., ... efforts to solicit its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its Board of Directors to recommend to the stockholders that they approve such proposal. Notwithstanding the foregoing, if any such time of an Authorized Share ... smart grill technologyWebDicerna Pharmaceuticals. 75 Hayden Avenue Lexington, MA 02421. 33 Hayden Avenue Lexington, MA 02421. 4949 Pearl East Circle Suite 100 Boulder, CO 80301. Contact … hillsboro funeral home stratford peiWebInvestor Relations. Deciphera Pharmaceuticals (DCPH) is a biopharmaceutical company focused on discovering, developing, and delivering important new medicines to patients for the treatment of cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to execute our strategy to develop ... hillsboro flatbed for sale near me